
Please try another search
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company’s lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.
Name | Age | Since | Title |
---|---|---|---|
Joseph V. Bonventre | 71 | - | Chairperson of Scientific Advisory Board |
Gregory P. Downey | - | - | Member of Scientific Advisory Board |
Michael Koren | - | - | Member of Scientific Advisory Board |
Anupam Agarwal | - | - | Member of Scientific Advisory Board |
Sumit Mohan | - | - | Member of Scientific Advisory Board |
Jack Boyd | - | - | Member of Scientific Advisory Board |
Matthew Cooper | - | - | Member of Scientific Advisory Board |
Matthew R. Weir | - | - | Member of Scientific Advisory Board |
Ken Newell | - | - | Member of Scientific Advisory Board |
Karen J. Wilson | 58 | 2020 | Independent Non-Employee Director |
Gilbert S. Omenn | 79 | 2020 | Independent Non-Employee Director |
Victor F. Ganzi | 74 | 2018 | Lead Independent Non-Employee Director |
Allen Richard Nissenson | 74 | 2020 | Independent Non-Employee Director |
Jay R. Venkatesan | 50 | 2018 | President, CEO & Chairman |
Itzhak D. Goldberg | 73 | 1998 | Chairman Emeritus |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review